The Ferric Pyrophosphate Market presents strong growth opportunities driven by rising anemia cases, increasing demand for functional foods, and advancements in renal therapies. However, regulatory ...
Calcium pyrophosphate disease remains—50 years after its initial description—a challenging disease to diagnose and manage. Newly-reached consensus among European experts suggests standard nomenclature ...
Researchers have discovered two genes, RNF144B and ENPP1, that cause calcium pyrophosphate deposition (CPPD) disease in Americans of European and African descent. This crystalline arthritis is caused ...
In a first-of-its-kind genome-wide association study (GWAS) researchers have discovered two genes, RNF144B and ENPP1, that cause calcium pyrophosphate deposition (CPPD) disease in Americans of ...
Please provide your email address to receive an email when new articles are posted on . Utilization of pyrophosphate imaging to identify patients with cardiac amyloidosis has increased, although ...
This article was originally published in HCPLive® and has been lightly edited. The risk of fractures is almost doubled for individuals with acute calcium pyrophosphate crystal arthritis compared to ...
Symptomatic CPPD disease (formerly known as “pseudogout”) is more common in older than younger adults and typically affects joints with previous damage. Chondrocalcinosis visible on radiographs ...
Canvax’s new inorganic pyrophosphate is designed for in-vitro transcription reactions. Canvax, a European supplier of enzymes, recombinant proteins, and similar products, announced the release of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results